Literature DB >> 21180638

Do amyloid-lowering strategies work clinically?

Rob J van Marum1.   

Abstract

Year:  2009        PMID： 21180638      PMCID： PMC3002619          DOI： 10.1177/1756285608101376

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN： 1756-2856            Impact factor:   6.570


× No keyword cloud information.
  18 in total

Review 1.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

2.  Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial.

Authors:  Lars Lannfelt; Kaj Blennow; Henrik Zetterberg; Stellan Batsman; David Ames; John Harrison; Colin L Masters; Steve Targum; Ashley I Bush; Ross Murdoch; Janet Wilson; Craig W Ritchie
Journal:  Lancet Neurol       Date:  2008-07-30       Impact factor: 44.182

3.  Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study.

Authors:  G Stennis Watson; Brenna A Cholerton; Mark A Reger; Laura D Baker; Stephen R Plymate; Sanjay Asthana; Mark A Fishel; J Jacob Kulstad; Pattie S Green; David G Cook; Steven E Kahn; Michelle L Keeling; Suzanne Craft
Journal:  Am J Geriatr Psychiatry       Date:  2005-11       Impact factor: 4.105

4.  A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease.

Authors:  P S Aisen; D Saumier; R Briand; J Laurin; F Gervais; P Tremblay; D Garceau
Journal:  Neurology       Date:  2006-11-02       Impact factor: 9.910

Review 5.  The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.

Authors:  John Hardy; Dennis J Selkoe
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

Review 6.  Current and future therapy in Alzheimer's disease.

Authors:  Robert J van Marum
Journal:  Fundam Clin Pharmacol       Date:  2008-06       Impact factor: 2.748

Review 7.  PPARs in the brain.

Authors:  Michael T Heneka; Gary E Landreth
Journal:  Biochim Biophys Acta       Date:  2007-05-10

Review 8.  Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Steven T Dekosky; Pascale Barberger-Gateau; Jeffrey Cummings; André Delacourte; Douglas Galasko; Serge Gauthier; Gregory Jicha; Kenichi Meguro; John O'brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2007-08       Impact factor: 44.182

9.  Hope in Alzheimer's fight emerges from unexpected places.

Authors:  Trisha Gura
Journal:  Nat Med       Date:  2008-09       Impact factor: 53.440

10.  Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease.

Authors:  N C Fox; R S Black; S Gilman; M N Rossor; S G Griffith; L Jenkins; M Koller
Journal:  Neurology       Date:  2005-05-10       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.